1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Cytochrome P450

Cytochrome P450

P450

CYPs

Cytochrome p450 comprises a superfamily of heme-thiolate proteins named for the spectral absorbance peak of their carbon-monoxide-bound species at 450 nm. Having been found in every class of organism, including Archaea, the p450 superfamily is believed to have originated from an ancestral gene that existed over 3 billion years ago. Repeated gene duplications have subsequently given rise to one of the largest of multigene families. These enzymes are notable both for the diversity of reactions that they catalyze and the range of chemically dissimilar substrates upon which they act. Cytochrome p450s support the oxidative, peroxidative and reductive metabolism of such endogenous and xenobiotic substrates as environmental pollutants, agrochemicals, plant allelochemicals, steroids, prostaglandins and fatty acids. In humans, Cytochrome p450s are best known for their central role in phase I drug metabolism where they are of critical importance to two of the most significant problems in clinical pharmacology: drug interactions and interindividual variability in drug metabolism.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-146458
    Antibacterial agent 102
    Inhibitor
    Antibacterial agent 102 (compound 32) possesses potent in vitro and in vivo antibacterial activity, with MICs < 0.5 μg/mL in Staphylococcus aureus (S. aureus). Antibacterial agent 102 also moderately inhibits CYP3A4 with an IC50 value of 6.148 μM. Antibacterial agent 102 can reduce Methicillin-resistant Staphylococcus aureus (MRSA) load in thigh infected mice.
    Antibacterial agent 102
  • HY-116214S1
    Cyprodinil-13C6
    Inducer
    Cyprodinil-13C6 (CGA-219417-13C6) is the 13C6 labeled Cyprodinil (HY-116214). Cyprodinil (CGA-219417) is a broad-spectrum anilinopyrimidine fungicide and an activator of the aryl hydrocarbon receptor. Cyprodinil also has anti-androgenic and androgenic activities. Cyprodinil can inhibit the biosynthesis of methionine in plant-pathogenic fungi and protect fruits and vegetables from a variety of pathogens.
    Cyprodinil-<sup>13</sup>C<sub>6</sub>
  • HY-121789
    Proadifen
    Inhibitor
    Proadifen is a compound that inhibits cytochrome P450 activity, which can change the excitability of catecholamine-secreting neurons in the brain and have different effects on neurons in different brain regions.
    Proadifen
  • HY-116643
    SU 10603
    Inhibitor
    SU 10603 is a specific inhibitor of P45017α (P450c17; CYP17A1).
    SU 10603
  • HY-115754
    S-(N-PhenethylthiocarbaMoyl)-L-cysteine
    Inhibitor
    S-(N-PhenethylthiocarbaMoyl)-L-cysteine (PEITC-Cys), an anticarcinogenic agent, has antileukemic activity. S-(N-PhenethylthiocarbaMoyl)-L-cysteine inhibits DNA synthesis in HL60 cells. S-(N-PhenethylthiocarbaMoyl)-L-cysteine is a P450 inhibitor.
    S-(N-PhenethylthiocarbaMoyl)-L-cysteine
  • HY-E70458
    Human CYP3A4,High-Reductase
    Human CYP3A4, High-Reductase, a recombinant CYP3A4, is a multifunctional enzyme with a wide range of substrates.
    Human CYP3A4,High-Reductase
  • HY-162784
    CYP51-IN-19
    Inhibitor
    CYP51-IN-19 (compound C07) is a potent CYP51 inhibitor. CYP51-IN-19 stimulates reactive oxygen species (ROS) and exhibits potent fungicidal activity.
    CYP51-IN-19
  • HY-13832S3
    cis-Atovaquone-d4
    Inhibitor
    cis-Atovaquone-d4 is deuterium labeled Atovaquone. Atovaquone (Atavaquone) is a potent, selective and orally active inhibitor of the parasite’s mitochondrial cytochrome bc1 complex. Atovaquone is against human and  P. falciparum cytochrome bc1 activity with IC50 values of 460 nM and 2.0 nM, respectively. Atovaquone is an antimalarial agent and has the potential for the investigation of neumocystis pneumonia, toxoplasmosis, malaria, and babesia[1][2].
    cis-Atovaquone-d<sub>4</sub>
  • HY-E70500
    Human CYP4F3,Low-Reductase+b5
    Human CYP4F3, Low-Reductase+b5, a recombinant CYP4F3, is a member of the CYP enzyme family. CYP4F3 is an enzyme mainly expressed in polymorphonuclear leukocytes.
    Human CYP4F3,Low-Reductase+b5
  • HY-106019A
    Liarozole hydrochloride
    Inhibitor
    Liarozole hydrochloride is an imidazole derivative and orally active retinoic acid (RA) metabolism-blocking agent (RAMBA). Liarozole hydrochloride inhibits the cytochrome P450 (CYP26)-dependent 4-hydroxylation of retinoic acid (IC50=7 μM), resulting in increased tissue levels of retinoic acid. Liarozole hydrochloride shows antitumoral properties.
    Liarozole hydrochloride
  • HY-151253
    CYP2C1/CYP2C19-IN-2
    Inhibitor
    CYP2C1/CYP2C19-IN-2 (compound 21d) is a potent CYP2C9/CYP2C19 inhibitor, possessing no hepatotoxicity and ames toxicity. CYP2C1/CYP2C19-IN-2 can be used in study of anti-ZIKV.
    CYP2C1/CYP2C19-IN-2
  • HY-N3841R
    ε-​Viniferin (Standard)
    Inhibitor
    ε-Viniferin (Standard) is the analytical standard of ε-Viniferin. This product is intended for research and analytical applications. ε-Viniferin (epsilon-Viniferin), the dimer of Resveratrol and can be isolated from Vitis vinifera, displays a potent inhibitory for all the CYP activities, with Ki values from 0.5-20 μM. ε-Viniferin possesses potent antioxidant, anti-inflammatory, anti-diabetic, and anti-neurodegenerative capacity.
    ε-​Viniferin (Standard)
  • HY-N0382S
    Galangin-13C3
    Inhibitor
    Galangin-13C3 is the 13C-labeled Galangin. Galangin (Norizalpinin) is an agonist/antagonist of the arylhydrocarbon receptor. Galangin (Norizalpinin) also shows inhibition of CYP1A1 activity.
    Galangin-<sup>13</sup>C<sub>3</sub>
  • HY-14874S
    Topiroxostat-d4
    Inhibitor
    Topiroxostat-d4 is deuterium labeled Topiroxostat. Topiroxostat (FYX-051) is a potent and orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 value of 5.3 nM and a Ki value of 5.7 nM. Topiroxostat exhibits weak CYP3A4-inhibitory activity (18.6%). Topiroxostat has the potential for hyperuricemia treatment[1][2].
    Topiroxostat-d<sub>4</sub>
  • HY-E70485
    Human CYP2C9,High-Reductase+b5
    Human CYP2C9, High-Reductase+b5, a recombinant CYP2C9, is one of the most important cytochrome P450 (CYP) enzymes. Human CYP2C9, Low-Reductase is responsible for drug metabolism reactions that occur in human populations.
    Human CYP2C9,High-Reductase+b5
  • HY-135023
    5-trans-PGE2
    Activator
    5-trans-PGE2 (5-trans Prostaglandin E2) is the active isomer of PGE2 and a potent activator of aromatase. Supplements the process of paracrine signaling between epithelial cells (expressing high levels of PGE2) and surrounding stromal cells (expressing high levels of aromatase). This process is involved in the growth and development of breast cancer.
    5-trans-PGE2
  • HY-150581
    CYP3A4-IN-3
    Inhibitor
    CYP3A4-IN-3 is a high-affinity specific inhibitor of cytochrome P450 3A4 (CYP3A4) with the IC50 value of 0.075 μM. CYP3A4-IN-3 is a ritonavir analogue, but with a simpler structure and twice the inhibitory effect of ritonavir. CYP3A4-IN-3 is used as an antiviral agent and immunosuppressant.
    CYP3A4-IN-3
  • HY-N0125R
    Diosmetin (Standard)
    Inhibitor
    Diosmetin (Standard) is the analytical standard of Diosmetin. This product is intended for research and analytical applications. Diosmetin is a natural flavonoid which inhibits human CYP1A enzyme activity with an IC50 of 40 μM in HepG2 cell.
    Diosmetin (Standard)
  • HY-172393
    TCF4/β-catenin-IN-1
    Inhibitor
    TCF4/β-catenin-IN-1 (Compound 8b) is an inhibitor of TCF4/β-catenin, and induces apoptosis. TCF4/β-catenin-IN-1 up-regulates p53, caspase-3, caspase-8, caspase-9 levels and Bax protein expression as well as down-regulates Bcl-2 protein expression. TCF4/β-catenin-IN-1 can inhibit CYP3A4, CYP1A2, CYP2C19, and shows promising cytotoxic activity in cancer cells.
    TCF4/β-catenin-IN-1
  • HY-118407
    LY56110
    Inhibitor
    LY56110 is an orally active aromatase inhibitor. LY56110 inhibits P-450-dependent p-nitroanisole O-demethylation and ethylmorphine N-demethylation in hepatic microsomes isolated from rat, with the IC50 of 2.5 and 11 μΜ, respectively. LY56110 can be used for neurological disorder study.
    LY56110
Cat. No. Product Name / Synonyms Application Reactivity

CYP1

CYP2

CYP3

CYP4

CYP11

CYP17

Aromatase/CYP19A1

CYP26

CYP51

CYP1A2

CYP2D6

CYP2C9

CYP2C19

CYP3A4

CYP17A1

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Cytochrome P450 Inducers, Degraders, Inhibitors, Activators & Modulators
Product NameCYP1CYP2CYP3CYP4CYP11CYP17Aromatase/CYP19A1CYP26CYP51CYP1A2CYP2D6CYP2C9CYP2C19CYP3A4CYP17A1Purity    
Verapamil  
CYP3
            99.96%
Apigenin 
CYP2
             99.22%
Fenofibrate 
CYP2C19, IC50: 0.2 μM
CYP2B6, IC50: 0.7 μM
CYP2C9, IC50: 9.7 μM
CYP2C8, IC50: 4.8 μM
CYP3A4, IC50: 142.1 μM
            99.97%
Verapamil hydrochloride  
CYP3
            99.98%
Clopidogrel-β-D-glucuronide 
CYP2C8
             
Letrozole      
Aromatase
        99.95%
Ketoconazole  
CYP3
CYP4
           99.51%
Abiraterone     
CYP17
         99.88%
1-Aminobenzotriazole 
CYP2
CYP3
            99.88%
Abiraterone acetate     
CYP17
         99.96%
Stiripentol 
CYP2
CYP3
            99.99%
Clarithromycin  
CYP3
            99.90%
Cepharanthine 
CYP2E1, IC50: 25.62 μM
CYP2C9, IC50: 24.57 μM
CYP3A4, IC50: 16.29 μM
            99.87%
Gemfibrozil 1-O-β-glucuronide 
CYP2C8, IC50: 4.07 μM
             99.87%
Diosmetin
CYP1
              99.63%
Salvianolic acid C 
CYP2C8, Ki: 4.82 μM
CYP2J2, Ki: 5.75 μM
             99.94%
Oleuropein      
Aromatase
        99.05%
Fomepizole 
CYP2E1
             99.67%
Talarozole       
CYP26
       99.61%
HET0016   
CYP4
           99.69%
(S)-Mephenytoin 
CYP2
             99.85%
Galangin
CYP1
              99.96%
Anastrozole      
Aromatase
        99.99%
Sulfaphenazole 
CYP2C9
             99.85%
Cobicistat  
CYP3
            99.77%
Gemfibrozil
CYP1A2, Ki: 82 μM
CYP2C9, Ki: 5.8 μM
CYP2C19, Ki: 24 μM
CYP2C8, Ki: 69 μM
             99.91%
Exemestane      
Aromatase
        99.83%
Clobetasol propionate  
CYP3A5, IC50: 0.206 μM
CYP3A4, IC50: 15.6 μM
            99.85%
Troleandomycin  
CYP3
            ≥98.0%
Schisandrin A  
CYP3A, IC50: 6.6 μM
            99.89%
Isavuconazole  
CYP3
            99.99%
Clopidogrel hydrogen sulfate 
CYP2B6, IC50: 18.2 nM
CYP2C19, IC50: 524 nM
             99.43%
Bergamottin
CYP1A1, Ki: 10.703 nM
CYP1A1, IC50: 0.192 μM
CYP1A2, IC50: 5.077 μM
CYP2B2, IC50: 4.535 μM
CYP2B1, IC50: 9.495 μM
             99.80%
TMS
CYP1B1, IC50: 6 nM
CYP1A1, IC50: 300 nM
CYP1A2, IC50: 3.1 μM
CYP1B1, Ki: 3 nM
              99.40%
Gentiopicroside 
CYP2
             99.83%
Ginsenoside C-K 
CYP2C9, IC50: 32 μM
CYP2A6, IC50: 63.6 μM
             99.92%
K777  
CYP3
            99.77%
AS1810722  
CYP3A4
            98.14%
Alpha-Naphthoflavone      
Aromatase
        98.54%
Olivetol 
CYP2
             99.81%
Ginsenoside Rd
CYP1A2, IC50: 78.4 μM
CYP2D6, IC50: 58 μM
CYP2C9, IC50: 85.1 μM
CYP3A4, IC50: 81.7 μM
            99.88%
Pregnenolone 16α-carbonitrile 
CYP2
CYP3
            98.48%
Atazanavir  
CYP3
            99.86%
Tetrahydrocurcumin 
CYP2C9
CYP3A4
            98.96%
Phillyrin
CYP1
CYP2
             98.99%
7-Ethoxyresorufin
CYP1
              99.61%
Topiroxostat  
CYP3
            99.06%
Dronedarone  
CYP3
            99.93%
Rhapontigenin
CYP1A1, IC50: 400 nM
              99.66%
Tebuconazole        
CYP51
      99.66%
Atazanavir sulfate  
CYP3
            99.94%
Clomethiazole 
CYP2
             98.65%
Curcumenol  
CYP3
            99.98%
Galeterone     
CYP17
         99.87%
Bergaptol  
CYP3
            99.44%
Dihydrokavain           
CYP2C9, IC50: 130.95 μM
CYP2C19, IC50: 10.05 μM
CYP3A4, IC50: 78.59 μM
 99.94%
Chlorzoxazone 
CYP2
             99.84%
Ticlopidine 
CYP2
CYP3
            99.56%
Endoxifen      
Aromatase
        99.42%
Schisandrol B 
CYP2
CYP3A
            99.99%
5,7-Dimethoxyflavone  
CYP3A
            99.86%
Mephenytoin 
CYP2
             99.96%
CYP3cide  
CYP3A4, EC50: 30 nM
CYP3A5, EC50: 17 μM
CYP3A7, EC50: 71 μM
            99.92%
Endoxifen hydrochloride      
Aromatase
        98.75%
Fadrozole hydrochloride      
Aromatase
        99.91%
(S)-(+)-N-3-Benzylnirvanol            
CYP2C19, Ki: 250 nM
  99.82%
Oteseconazole           
CYP2C9, IC50: 99 μM
CYP2C19, IC50: 72 μM
  99.46%
BMS-986202 
CYP2C19, IC50: 14 μM
             99.92%
LKY-047 
CYP2J2, IC50: 1.7 μM
             99.94%
Cecropin B  
CYP3
            99.00%
Utreloxastat         
CYP1A2, IC50: > 5.3 μM
     99.69%
Dihydromethysticin  
CYP3
            99.94%
Cedrol 
CYP2
CYP3
            99.76%
Columbamine chloride             
CYP3A4, IC50: 30.6 μM
 98.63%
Obtusifoliol        
CYP51
      99.86%
Fipronil
CYP1
CYP2
CYP3
            98.98%
AZD7325
CYP1A2
 
CYP3A4
            99.71%
Casopitant mesylate  
CYP3A4
            99.84%
Fadrozole      
Aromatase
        99.78%
Isosilybin  
CYP3
            99.95%
APD668 
CYP2C9, Ki: 0.1 μM
             99.73%
Ginsenoside F1 
CYP2
CYP3A4
            ≥99.0%
Oxiconazole nitrate  
CYP3A4
            ≥98.0%
Cephaeline dihydrochloride 
CYP2
             99.84%
6',7'-Dihydroxybergamottin  
CYP3A4
            ≥99.0%
Liarozole       
CYP26, IC50: 7 μM
       98.83%
Harmalol hydrochloride
CYP1
              99.72%
Flavanone      
Aromatase
        99.84%
β-​Apo-​8'-​carotenal
CYP1A1
CYP1A2
              
Seviteronel     
CYP17
         99.83%
Aminoglutethimide      
Aromatase
        98.79%
Friedelin 
CYP2
CYP3
            ≥99.0%
Clitorin      
Aromatase, IC50: 77.41 nM
        98.06%
Ezutromid
CYP1
              98.10%
Dihydrolanosterol        
CYP51
      99.56%
TP0472993   
CYP4A11, IC50: 140 nM
CYP4F2, IC50: 40 nM
           98.69%
MS-PPOH 
CYP2
             99.27%
Dagrocorat 
CYP2D6
CYP3A
            99.90%
PC945        
CYP51A, IC50: 0.23 μM
CYP51B, IC50: 0.22 μM
      99.27%
AMG-208  
CYP3A4, IC50: 32 μM
            99.86%
Oxolamine citrate 
CYP2B1
CYP2B2
             99.87%
Tetrahydropiperine
CYP1A1, IC50: 23 μM
              99.41%
Nicotelline       
CYP26, Ki: ≥300 μM
       99.92%
2-Phenyl-2-(1-piperidinyl)propane
CYP1A2, IC50: >300 μM
CYP2B6, IC50: 5.1 μM
CYP2B6, Ki: 5.6 μM
CYP2D6, IC50: 74 μM
CYP2A6, IC50: >300 μM
CYP2C8, IC50: >300 μM
CYP2C9, EC50: >300 μM
CYP2C19, IC50: >300 μM
CYP2E1, IC50: >300 μM
CYP3A, IC50: 200 μM
            99.72%
Quilseconazole        
CYP51
      98.98%
(R)-(+)-Aminoglutethimide      
Aromatase
        
Sudan IV
CYP1A1
              ≥98.0%
Columbamine             
CYP3A4, IC50: 30.6 μM
 99.70%
NN1177 TFA             
CYP3A4
 98.66%
Orteronel     
CYP17
         99.70%
Dapaconazole       
CYP26, IC50: 1.4 μM
       99.76%
N-Nornuciferine 
CYP2
             99.94%
Linderane 
CYP2
             99.61%
D4-abiraterone     
CYP17
         99.75%
IDO1-IN-19 
CYP2C9, IC50: 8.64 μM
             98.52%
Liarozole dihydrochloride       
CYP26, IC50: 7 μM
       ≥99.0%
Chrysosplenetin  
CYP3A
            99.68%
Fenofibrate (Standard) 
CYP2B6
CYP2C19
CYP2C8
CYP2C9
CYP3A4
            99.91%
Mefentrifluconazole        
CYP51A, Kd: 0.5 nM
      99.61%
2,6-Dimethylquinoline
CYP1A2, IC50: 3.3 μM
CYP2B6, IC50: 480 μM
             99.95%
ACP-5862 
CYP2C8
CYP3A4
            98.41%
DMU2105
CYP1B1, IC50: 10 nM
CYP1A1, IC50: 742 nM
              99.54%
Fomepizole hydrochloride 
CYP2E1
             99.85%
Nampt-IN-5  
CYP3, IC50: 0.7 nM
            98.02%
Phortress
CYP1
              99.25%
α-​Terpinyl acetate 
CYP2B6, Kd: 5.4  μM
             
ML252
CYP1A2, IC50: 6.1 μM
CYP2C9, IC50: 18.9 μM
CYP2D6, IC50: 19.9 μM
CYP3A4, IC50: 3.9 μM
            99.9%
CYP19A1-IN-2      
Aromatase
        98.88%
CYP1B1-IN-4
CYP1B1, IC50: 0.2 nM
CYP1A1, IC50: 3.98 μM
              99.09%
Melperone          
CYP2D6
    99.24%
Polygalaxanthone III 
CYP2
             99.76%
ONT-993 
CYP2D6, IC50: 7.9 μM
             99.85%
Carbosulfan
CYP1
CYP2
CYP3
            ≥98.0%
BI 653048
CYP1A2, IC50: 50 μM
CYP2D6, IC50: 41 μM
CYP2C9, IC50: 12 μM
CYP2C19, IC50: 9 μM
CYP3A4, IC50: 8 μM
            99.84%
BI 689648    
CYP11
          99.20%
DMU2139
CYP1B1, IC50: 9 nM
CYP1A1, IC50: 795 nM
              ≥98.0%
Pradefovir mesylate  
CYP3
            99.89%
Antihistamine-1 
CYP2D6, IC50: 5.4 μM
             99.45%
Exemestane (Standard)      
Aromatase
        99.63%
Abiraterone acetate (Standard)     
CYP17
         99.85%
8-Geranyloxypsoralen  
CYP3
            99.93%
SDZ285428        
CYP51
      98.00%
Dagrocorat hydrochloride 
CYP2D6
CYP3A
            99.85%
CYP4A11/CYP4F2-IN-1   
CYP4A11, IC50: 19 nM
CYP4F2, IC50: 17 nM
           99.82%
Chlorzoxazone (Standard) 
CYP2
             99.81%
SR9186  
CYP3
            98.06%
Seviteronel (R enantiomer)     
CYP17
         98.82%
Letrozole-d4      
Aromatase
        99.82%
Abiraterone decanoate     
CYP17
         99.69%
hCYP3A4 Fluorogenic substrate 1  
CYP3A4, Km: 0.36 μM
            99.27%
MCH-1 antagonist 1  
CYP3A4, IC50: 10 μM
            
1'-Hydroxy bufuralol 
CYP2
             
Eriodictyol chalcone      
Aromatase
        
ε-​Viniferin
CYP1A2, Ki: 5 μM ((EROD))
CYP2B6, Ki: 3 μM ((BROD))
CYP2A6, Ki: 60 μM ((COH))
CYP2E1, IC50: 25 μM ((CHZ))
CYP3A4, Ki: 10 μM ((TST))
CYP4A, IC50: 15 μM ((LwOH))
           ≥98.0%
Gemfibrozil (Standard)
CYP1A2
CYP2C19
CYP2C8
CYP2C9
             99.90%
BMS-819881  
CYP3A4, EC50: 13 μM
            99.78%
YM511      
Aromatase
        99.73%
CYP11B2-IN-1    
CYP11B2, IC50: 2.3 nM
CYP11B1, IC50: 142 nM
          99.83%
Revexepride  
CYP3A4
            99.84%
Apigenin (Standard) 
CYP2
             
1-(Isothiazol-3-yl)ethan-1-one 
CYP2E1
             
Bucolome 
CYP2
             98.93%
Tabimorelin  
CYP3A4
            
Azamulin  
CYP3A, IC50: 0.03-0.24 μM
            
Resorufin methyl ether
CYP1
              99.75%
4,5-Dimethoxycanthin-6-one
CYP1A2, IC50: 1.7 μM
CYP1A2, Ki: 2.6 μM
              98.68%
Dibenzothiophene
CYP1
              99.47%
Vorozole      
Aromatase
        
ODM-204     
CYP17
         
IHMT-PI3Kδ-372 
CYP2C9, IC50: 2.7 μM
             
BMS-986339 
CYP2C8, IC50: 8 μM
CYP2C9, IC50: 13.5 μM
             
Fadrozole hydrochloride hemihydrate      
Aromatase
        
Anastrozole-d12      
Aromatase
        
Endoxifen-d5      
Aromatase
        
CYP3A4-IN-2  
CYP3A4, IC50: 0.055 μM
            
Clarithromycin (Standard)  
CYP3
            
CYP11B1-IN-2
CYP1A2, IC50: >10 μM
CYP2C9, IC50: >10 μM
CYP2C19, IC50: >10 μM
CYP2D6, IC50: >10 μM
CYP2E1, IC50: >10 μM
CYP3A4, IC50: >10 μM
 
CYP11B1, IC50: 9 ± 2 nM (human CYP11B1)
CYP11B1, IC50: 25 nM (rat CYP11B1)
CYP11B2, IC50: 1121 ± 237 nM
          
Antitumor agent-88
CYP1A1, Ki: 1.4 μM
              
17-HETE
CYP1B1
              
SYN20028567      
Aromatase
        
P-gp inhibitor 23             
CYP3A4
 
CYP4Z1-IN-1 
CYP2D6, IC50: >10 000 nM
CYP2C9, IC50: >10 000 nM
CYP3A4, IC50: >10 000 nM
CYP4Z1, IC50: 41.8 ± 1.4 nM
CYP4F11, IC50: 291.3 ± 46 nM
CYP4F12, IC50: 1598.3 ± 5 nM
           
CYP3A4-IN-3  
CYP3A4, IC50: 0.075 μM
            
Diosmetin (Standard)
CYP1
              
CYP1B1-IN-2
CYP1B1, IC50: 0.52 nM
CYP1A1, IC50: 16.7 nM
CYP1A2, IC50: 94.2 nM
              
ERα degrader 9      
Aromatase
        
Ginsenoside C-K (Standard) 
CYP2A6
CYP2C9
             
CYP17-IN-1     
CYP17
         
FGFRs-IN-1         
CYP1A2, IC50: 26.33 μM
CYP2D6, IC50: 9.27 μM
 
CYP2C19, IC50: 11.46 μM
  
CYP1B1-IN-5
CYP1B1, IC50: 4.7 nM
CYP1A1, IC50: 190.7 nM
CYP1A2, IC50: 585.7 nM
              
FGFR-IN-10 
CYP2C9, IC50: 3.33 μM
CYP2C19, IC50: 18.75 μM
CYP2D6, IC50: 4.34 μM
CYP3A4, IC50: 0.69 μM
            
CYP17A1/HDAC6-IN-1              
CYP17A1, IC50: 0.284 μM
hCYP1B1-IN-2
CYP1B1, IC50: 0.040 nM
CYP1A1, IC50: 0.38 nM
              
Ginsenoside Rd (Standard)
CYP1A2
CYP2C9
CYP2D6
CYP3A4
            
Melperone hydrochloride          
CYP2D6
    
Antiproliferative agent-53-d3 
CYP2C19, IC50: 0.77 μM
CYP2C9, IC50: 3.1 μM
CYP2D6, IC50: 17.3 μM
CYP3A4, IC50: 14.6 μM
            
Oxolamine hydrochloride 
CYP2B1
CYP2B2
             
CYP17A1-IN-1     
CYP17, IC50: 26 nM
         
HIV-1 inhibitor-40 
CYP2C9, IC50: 5.16 μM
CYP2C19, IC50: 4.51 μM
             
BChE-IN-33 
CYP2C19
CYP2C9
CYP2D6
             
ASN-001              
CYP17A1
Anticancer agent 78      
Aromatase
        
CYP3A4-IN-1  
CYP3A4, IC50: 0.085 μM
            
CYP51/HDAC-IN-1        
CYP51
      
Exemestane-13C3      
Aromatase
        
Kushenol K  
CYP3A4, Ki: 1.35 μM
            
TRPV1 antagonist 10
CYP1A2, IC50: 28.31 μM
CYP2C9, IC50: 42.85 μM
CYP2C19, IC50: 9.23 μM
CYP2D6, IC50: >100 μM
CYP3A4M, IC50: 8.73 μM
            
N-Desmethyl diltiazem hydrochloride  
CYP3A7
            
EGFR-IN-137      
Aromatase, IC50: 4.01 μM
        
PROTAC ERα Degrader-9      
Aromatase, IC50: 4.6 μM
        
CYP1B1-IN-3
CYP1B1, IC50: 6.6 nM
CYP1A1, IC50: 347.3 nM
CYP1A2, IC50: >10000 nM
              
Antitumor agent-87
CYP1A1, Ki: 0.23 μM
              
DL-Acetylshikonin
CYP1A2, IC50: 4.0 μM
CYP2A6, IC50: 3.8 μM
CYP2B6, IC50: 2.0 μM
CYP2C8, IC50: 1.4 μM
CYP2C9, IC50: 3.3 μM
CYP2C19, IC50: 2.5 μM
CYP2D6, IC50: 2.5 μM
CYP2E1, IC50: 2.7 μM
CYP2J2, IC50: 3.3 μM
CYP3A, IC50: 2.3 μM
            
Exemestane-d2      
Aromatase
        
5,7,2',6'-Tetrahydroxyflavone  
CYP3A4, IC50: 7.8 μM
            
Oxolamine 
CYP2B1
CYP2B2
             
7-Ethoxy-4-methylcoumarin
CYP1A1
CYP2B6
CYP2B4
             99.44%
BNS808
CYP1A2, IC50: 18.0 μM
CYP2C9, IC50: 2.99 μM
CYP2C19, IC50: 8.33 μM
CYP2D6, IC50: >50 μM
             
Aromatase-IN-3      
Aromatase, IC50: 54 nM
        
BI 653048 phosphate
CYP1A2, IC50: 50 μM
CYP2D6, IC50: 41 μM
CYP2C9, IC50: 12 μM
CYP2C19, IC50: 9 μM
CYP3A4, IC50: 8 μM
            
Exemestane-d3      
Aromatase
        
CFG920    
CYP11B2
CYP17
         
Nav1.7-IN-8 
CYP2C9, IC50: 0.17 μM
CYP3A4, IC50: 0.077 μM
            
Galangin (Standard)
CYP1
              
JNK-IN-14          
CYP2D6, IC50: 26.7 ± 0.5 nM
  
CYP3A4, IC50: 383.0 ± 1. nM
 
Fenofibrate-d6 
CYP2
CYP3
            99.70%
Oxiconazole  
CYP3A4
            
GlcN-6-P Synthase-IN-1  
CYP3
            
Tetrahydrocurcumin-d6 
CYP2
CYP3
            
Antibacterial agent 132      
Aromatase
        
1,2,3,6,7,8-Hexachlorodibenzofuran
CYP1A1
              
Androsta-1,4,6-triene-3,17-dione      
Aromatase
        
7-Hydroxyflavanone      
Aromatase
        99.59%
Phortress free base
CYP1
              
PROTAC CYP1B1 degrader-2
CYP1B1, DC50: 1 nM
              
hCYP3A4-IN-1  
CYP3A4, IC50: 43.93 nM
            
Monoamine oxidase/Aromatase-IN-1      
Aromatase
        
RO6889678  
CYP3A4
            
CYP51/PD-L1-IN-4        
CYP51, IC50: 0.17 ± 0.0 μM
      
Tabimorelin hemifumarate  
CYP3A4
            
Aromatase-IN-2      
Aromatase
        99.83%
17(S)-HETE
CYP1B1
              
Licopyranocoumarin  
CYP3A4, IC50: 32 μM
            
Methysticin
CYP1A1
              
Sudan IV (Standard)
CYP1A1
              
Thujopsene 
CYP2B6, IC50: 1.3 μM
CYP2C19, IC50: 13.6 μM
CYP2C8, IC50: 29.8 μM
CYP2C9, IC50: 44.9 μM
CYP3A4, IC50: 12.6 μM
            
CYP11B2-IN-2    
CYP11B2, IC50: 0.3 nM
CYP11B1, IC50: 3.8 nM
          
10-Hydroxywarfarin           
CYP2C9, IC50: 1.6 μM
   
Isolimonexic acid      
Aromatase
        
Melperone (Standard)          
CYP2D6
    
Melperone-d4 hydrochloride          
CYP2D6
    99.84%
CYP1B1 ligand 3
CYP1B1, IC50: 11.9 nM
CYP1A1, IC50: 278.7 nM
CYP1A2, IC50: 3913.5 nM
              
CYP3A4-IN-4  
CYP3A4
            
Cloperidone           
CYP2C9, IC50: 17.7 μM
   
CYP51/Hsp90-IN-1        
CYP51
      
Sudan IV-d6
CYP1A1
              
CYP4Z1-IN-2   
CYP4Z1, Ki: 2.2 μM
           
ML252 hydrochloride
CYP1A2, IC50: 6.1 μM
CYP2C9, IC50: 18.9 μM
CYP2D6, IC50: 19.9 μM
CYP3A4, IC50: 3.9 μM
            
Sorafenib N-oxide             
CYP3A4, Ki: 15 μM
 
Org30958      
Aromatase